Researchers
Calls and Grants
We support research that brings scientific advances closer to patients
At FERO Cancer, we support outstanding translational cancer research projects that generate new knowledge, open up new opportunities for the future and advance increasingly personalised medicine through the development of new diagnostic and therapeutic strategies that help improve patients’ survival and quality of life.
FERO Cancer Grants 2027 Calls
Opening: 19 October 2026.
Closing: 13 November 2026 at 15:00.
Explore the different FERO Cancer Grants 2027 below, their features and the full guidelines for each call.
Did you miss the FERO Cancer Grants 2027 Info Day?
View the Info Day presentation for the main updates to the calls, key aspects of the application process and recommendations for preparing your application.
FERO Cancer Grant for Young Researchers 2027
We support research talent in translational oncology in the early stages of establishing an independent career.
Who is it for? Researchers with a PhD (2011–2021) who lead a recently established group (≤5 years) and have obtained their first competitive funding as principal investigator, from national or international and public or private sources, in the last 3 years.
Funding: €100,000 per grant.
Duration: up to 2 years.
Application period: 19 October – 13 November 2026, at 15:00.
FERO Cancer Grant for Young Physician-Researchers 2027
We support medical professionals’ research careers to help bring scientific advances into clinical practice and closer to patients.
Who is it for? Physician-researchers with a clinical specialty obtained through the MIR programme and related to cancer treatment, who obtained their PhD in the last 15 years and have secured competitive funding as principal investigator, from national or international and public or private sources, in the last 3 years.
Funding: €100,000 per grant.
Duration: up to 3 years.
Application period: 19 October – 13 November 2026, at 15:00.
FERO Paediatric Cancer Grant 2027
We promote new opportunities for paediatric cancer research to advance our understanding of the disease and develop better diagnostic and therapeutic strategies.
Who is it for? Researchers with a PhD and/or a cancer-related clinical specialty obtained through the MIR programme, with a proven track record in paediatric cancer research, who have secured competitive funding from national or international and public or private sources in the last 3 years.
Funding: €100,000 per grant.
Duration: up to 2 years.
Application period: 19 October – 13 November 2026, at 15:00.
FERO Women’s Cancer Grant 2027
We promote research into women’s cancers to advance increasingly precise and personalised prevention, diagnosis and treatment.
Who is it for? Researchers with a PhD and/or a cancer-related clinical specialty obtained through the MIR programme, with a proven track record in research into women’s cancers, who have secured competitive funding from national or international and public or private sources in the last 3 years.
Funding: €100,000 per grant.
Duration: up to 2 years.
Application period: 19 October – 13 November 2026, at 15:00.
FERO Lung Cancer Grant - The Ricky Rubio Foundation 2027
We accelerate translational lung cancer research to bring new diagnostic and therapeutic strategies into clinical practice.
Who is it for? Researchers with a PhD and/or a cancer-related clinical specialty obtained through the MIR programme, with a proven track record in lung cancer research, who have secured competitive funding from national or international and public or private sources in the last 3 years.
Funding: €100,000 per grant.
Duration: up to 2 years.
Application period: 19 October – 13 November 2026, at 15:00.
FERO Cancer Dr. Josep Baselga Grant 2027
We support advanced translational cancer research projects led by professionals with an established scientific track record and the potential to have a significant impact on clinical practice in the short or medium term.
Who is it for? Researchers with an established scientific track record, an MD and/or PhD, and at least 5 years’ experience leading an independent research programme, group or team, who have secured competitive funding from national or international and public or private sources in the last 3 years.
Funding: €300,000 per grant.
Duration: up to 3 years.
Application period: 19 October – 13 November 2026, at 15:00.
Contact
For any questions about the FERO Cancer Grants or the application process, you can contact us at beca@ferocancer.org.